The School of Dentistry earned the first National Institutes of Health grant under its new Center for Pain Therapeutics and Addiction Research, addressing pain in patients with head and neck carcinoma.

  Patrick Sung, DPhil, director of the Greehey Children’s Cancer Research Institute and associate dean for research at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) is the latest recipient of the 2024 Basser Global Prize. A leading researcher in the field of DNA damage repair and cancer biology, Sung has been awarded the […]

  David Gius, MD, PhD, professor in the Department of Radiation Oncology and assistant dean of research at The University of Texas Health Science Center at San Antonio (UT Health San Antonio), was named this year’s recipient of the prestigious American Society for Radiation Oncology (ASTRO) Career Recognition Mentorship Award. David Gius, MD, PhD Gius is associate cancer center director […]

  One in eight men will develop prostate cancer in their lifetime. Of those, one in 44 men will die of the disease. Those statistics from the American Cancer Society are startling. But men facing an advanced prostate cancer diagnosis who are seeking additional treatment options now have one more arrow in their quiver to […]

Dental care is crucial for cancer patients and survivors to help reduce complications, improve treatment tolerance and enhance overall quality of life, according to oral medicine specialist Tiffany Tavares, DDS, DMSc.

  The stars aligned perfectly during a night of celebration at the second annual President’s Luminary Honors event at The University of Texas Health Science Center at San Antonio. The annual event, which took place at the soon-to-open UT Health San Antonio Multispecialty and Research Hospital, paid tribute to the legacy of William L. Henrich, […]

  Simon Gayther, PhD, professor of medicine in the Division of Hematology and Oncology in the Joe R. and Teresa Lozano Long School of Medicine and founding director in the school’s Center for Inherited Oncogenesis at The University of Texas Health Science Center at San Antonio (UT Health San Antonio), received a $500,000 UT System […]

  Approximately 30% of individuals with myeloid malignancy diseases have a mutation in a certain gene called tet methylcytosine dioxygenase 2 (TET2). This gene is responsible for providing instructions on creating certain proteins and is known to have a tumor-suppressive function. A study published October 2 in Nature is the first to explain the pathway […]

  Female cancer patients at the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, have a new option to preserve their fertility before undergoing treatment. “It is extremely common that cancer patients will experience the loss of fertility and early menopause after gonadotoxic therapies required for many cancer patients,” said […]

  Pancreatic ductal adenocarcinoma (PDAC), a certain type of pancreatic cancer, is a ruthless killer with an average five-year survival rate of less than 10%. Most patients are diagnosed at a late stage when the cancer has already spread throughout their bodies. And the problem is only growing worse. By 2030, pancreatic cancer is expected […]